OptiBiotix partners with Zeon Lifesciences for India market

Life sciences business OptiBiotix Health has entered into an exclusive manufacturing and supply agreement with Zeon Lifesciences, it announced on Monday.

The AIM-traded firm said the agreement granted Zeon an exclusive license to manufacture and supply OptiBiotix's ‘SlimBiome’ weight management technology in India, in return for 50% of the profit.

It said the agreement would optimise the supply chain in southern Asia by leveraging Zeon's purchasing power, manufacturing efficiencies and partner network to scale up the manufacture and supply of SlimBiome.

Under the terms of the deal, Zeon would cover the cost for the registration of SlimBiome and any finished product containing SlimBiome with the Food Safety and Standard Authority of India (FSSAI).

It described the agreement as an “important step” in meeting the needs of major Indian and global corporates for SlimBiome, and SlimBiome containing products, in the large consumer markets of India and southern Asia.

“We are pleased to announce this exclusive manufacturing, supply and profit sharing agreement,” said OptiBiotix chief executive officer Stephen O'Hara.

“We chose Zeon due to their position as India's leading manufacturer of nutraceutical products, industry reputation, extensive national and international partner network, and their expertise in manufacturing high value nutraceutical products.”

O’Hara said the company believed partnering with Zeon was an “important step” in optimising the supply chain to facilitate the needs of existing and new corporate partners in India and Southern Asia, and anticipated further announcements in due course.

“We hope the combination of our strong science and Zeon's local knowledge and manufacturing expertise with our combined partner network will quickly help bring the benefits of SlimBiome technology to India's 29.8m obese men and women.”